CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Varied efforts involve states, cities, food buyers, and hospital groups.
Tillerson voices support for US collaboration on global infectious disease issues, including those involving HIV and malaria.
The observational study found 46% protection but is smaller than an earlier one that showed no protection.
Comprehensive biomedical research must continue its crucial role in preparing the world for the next pandemic or other far-reaching public health emergency, whether it be caused by a novel influenza strain, Ebola, or some other transmissible pathogen, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) and colleagues wrote in a commentary in the Journal
Iranian scientists report a 7.6% prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in almost 500 hospital food samples they tested, and the bacteria had high levels of resistance to other antibiotics, as well, according to a study yesterday in Antimicrobial Resistance & Infection Control.
In one case, relying on ultrasound alone would have given the mother false assurance.
The trial of 40 adults with 2 dose levels found the vaccine safe and immunogenic.
A potential new weapon to fight multidrug-resistant bacteria comes in a very, very small package.
Neutralizing monoclonal antibodies engineered from three humans infected with Zika virus protected non-human primates from contracting the mosquito-borne disease, according to a new study published in Science Translational Medicine.
California researchers have developed a rapid test to detect antibiotic susceptibility in urinary tract infections (UTIs) in less than 30 minutes, which could allow patients to be diagnosed and prescribed effective antibiotics during just one healthcare visit, according to a study today in Science Translational Medicine.
Scientists manipulate mosquitoes' abilities to host the parasite Plasmodium falciparum.
Six main strategies target disease in hot spot countries that drive much of the world's cholera activity.
The Saudi Arabian Ministry of Health (MOH) announced a new case of MERS-CoV today.
The patient is a 72-year-old man from Tabuk, a city in northwestern Saudi Arabia near the Jordanian border. He presented with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection and is in stable condition. The man had direct contact with camels, a known risk factor for contracting MERS.
The $170.2 million in BioShield funds covers late-stage development and buys up to 1.13 million vaccine regimens and an unspecified number of treatment courses of two Ebola drugs.
Investigators found rising nonsusceptibility in E coli isolates, but decreasing resistance in other gram-negative pathogens.
After a lag in reporting last week, the Saudi Arabian Ministry of Health (MOH) updated it information on MERS-CoV cases over the weekend, noting three new cases since the agency last reported on Sep 25.
The US total of H3N2v cases would rise to 50 if CDC tests confirm 18 Maryland presumed positives.
Transmission chain mapping points to prolonged colistin use in livestock and poultry.
The vaccine protected 78% of newborns from pertussis and 90% from hospitalized cases.
